Although it is not known the exact number employed in Maryland or the Baltimore site, Catalent has a total workforce of more ...

Contract development and manufacturing organization (CDMO) Abzena has announced the formation of a strategic partnership with ...

What seems certain is that space and low-orbit laboratories will become an integral tool for drug innovation within the ...

Biomanufacturing outsourcing growth is slowing, but political uncertainties, tariffs, and labor shortages are reshaping where ...

This case study explores challenges, requirements, and more in adopting next-gen technologies to maintain an edge in process ...

Contract development and manufacturing organization (CDMO) Matica Biotechnology has partnered with Calidi Biotherapeutics to ...

To ensure product safety and efficacy, protein therapeutics must meet defined quality characteristics immediately after manufacture as well at the end of their designated shelf lives. Many physical ...

Allogeneic therapies based on healthy-donor material should help to create scalable processes for “off-the-shelf” drugs, potentially reducing production costs and increasing accessibility, however, ...

Figure 1: Hierarchical model schematic; information from all base-level models is communicated to a top-level model through their respective matrices (T j) into a consensus matrix R. R is used to ...

The biopharmaceutical industry is at the forefront of technological advancements, with “biopharma 4.0” revolutionizing the way biomanufacturing is conducted (1). The concept combines automation, ...

Single-use bioprocess manufacturing systems increasingly are being implemented by the biopharmaceutical industry based on safety, time, and cost-reduction benefits. These disposable systems are used ...

RecipharmCobra Biologics, Keele (previously Cobra Biomanufacturing Plc) has been producing plasmid DNA for clinical trials for more than 10 years and has an approved site under the EU clinical trials ...